# Aggressive Versus Conservative Blood Glucose Control in Hospitalized Type 2 Diabetic Patients Using Detemir and Aspart Insulin

> **NCT00906529** · PHASE4 · WITHDRAWN · sponsor: **University of Texas Southwestern Medical Center**

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** Levemir (Detemir) and Novolog (Aspart) Insulin

## Key facts

- **NCT ID:** NCT00906529
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2009-05
- **Primary completion:** 2010-12
- **Final completion:** 2011-03
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2019-01-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00906529

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00906529, "Aggressive Versus Conservative Blood Glucose Control in Hospitalized Type 2 Diabetic Patients Using Detemir and Aspart Insulin". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00906529. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*